National Jewish Health


60th Annual Denver TB Course

presented by National Jewish Health

29 others would like to attend.

Register Now

Notification icon Wednesday, April 3, 2024 4 PM - Friday, April 5, 2024 4:45 PM America/Denver

Location Icon 1400 Jackson Street Denver, Colorado 80206

Event info


Hybrid Event

Since the introduction of effective chemotherapy, many changes have come about in the management of tuberculosis (TB). Most important have been the shift from sanatoria-based to general hospital and clinic-based treatment and the knowledge that active disease can reliably be prevented among those who are latently infected. With the development of effective drugs for TB, the significant advances in bacteriology, and increased knowledge about the treatment of latent TB infection, the approach to tuberculosis control has become increasingly sophisticated.

The 60th Annual Denver TB Course is a hybrid event  and provides a broad overview of active and latent TB including its epidemiology, transmission, pathogenesis, diagnosis, treatment and management. The purpose of this course is to present this body of knowledge to general internists, epidemiologists, preventative medicine, public health, infectious disease and chest specialists, physician assistants, nurse practitioners, registered nurses and other health care providers who will be responsible for the management and care of patients with tuberculosis.

Course Highlights:

  • Epidemiology of tuberculosis
  • Transmission and pathogenesis
  • Diagnosis and treatment of tuberculosis including MDR/XDR-TB
  • Diagnosis and treatment of latent tuberculosis infection
  • Emphasis on vulnerable populations such as pediatric and HIV co-infection
  • Interactive Contact Investigation Workshop 


  • Discuss the epidemiological features which are associated with increased risk for tuberculosis.
  • Explain the clinical manifestations of tuberculosis and how they differ in unique patient populations such as pediatrics or HIV co-infection.
  • Recognize the tools available for diagnosis of tuberculosis and their differences, advantages, and possible shortcomings.
  • Formulate a treatment regimen for a patient with drug susceptible or drug resistant tuberculosis while understanding the pharmacokinetics and potential toxicities of that regimen.
  • Discuss the importance and performance of contact investigation among persons exposed to new cases of communicable TB.


Physicians: National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

National Jewish Health designates this live activity for a maximum of 17.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.

Course Syllabus

Click HERE to view the syllabus

29 others would like to attend.

Register Now

Login to view comments. Click here to Login